Risky regulations: Is the FDA's clunky process impeding progress?

May 23, 2011 by MassDevice staff

U.S. House Rep. Erik Paulsen (R-Minn.) promises to revamp FDA policies he says are delaying life-saving technologies from hitting the market.

company

U.S. Rep. Erik Paulsen (R-Minn.) announced plans to push legislation to modernize and streamline FDA processes at the MedTech Investing Conference in Minneapolis last week.

High on Paulsen's priorities are the development of an "Innovation Pathway" for pioneering medical devices and blocking a proposed $20 billion tax on the medical device industry.

Paulsen said he expects to meet with Dr. Jeffrey Shuren, head of the federal watchdog agency's medical devices arm, to discuss his proposals.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Risky Regulations by FDA Regulatory ...

Comment viewing options

Select your preferred way to display the comments and click "Save settings" to activate your changes.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp